Related Experiment Video
Updated: Feb 17, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
Infection: a Cause of and Cure for Cancer
Jenna H Newman1, Andrew Zloza1,2
1Section of Surgical Oncology Research, Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903 USA.
Purpose Of Review:
This article provides a brief overview of the role that infections play in cancer emergence and cancer treatment.
Recent Findings:
A select number of pathogens have been reported to increase the incidence of specific cancers (directly through altering gene expression or indirectly through inducing chronic inflammation). These have been referred to as oncogenic pathogens. Conversely, a subset of pathogens has been demonstrated to preferentially cause lysis of tumor cells, leading to tumor regression and improved anti-tumor immunity. These have been termed oncolytic pathogens. However, the contribution of non-oncogenic, non-oncolytic pathogens to both tumor growth and regression is likewise being increasingly recognized.
Summary:
Pathogens have both the ability to cause and cure cancer. However, the mechanisms underlying these pathogen-mediated outcomes are not fully understood. With the recent emergence of interest in the immunotherapy of cancer, it is important that future studies focus specifically on preventing the negative effects of oncogenic infections, deconstructing the positive role of oncolytic pathogens, and finally providing insight into the dual roles of non-oncolytic, non-oncogenic pathogens so that anti-pathogen immune responses can be harnessed as a transformative means to treat cancer.
Insights
Infections can both cause and treat cancer. Understanding oncogenic and oncolytic pathogens is key to harnessing anti-pathogen immunity for cancer therapy.
Area of Science:
- Infectious disease
- Oncology
- Immunology
Background:
- Pathogens play a complex role in cancer development and treatment.
- Some pathogens are oncogenic, increasing cancer incidence.
- Others are oncolytic, selectively destroying tumor cells.
Purpose of the Study:
- To provide an overview of how infections influence cancer.
- To explore the dual roles of pathogens in cancer emergence and treatment.
Main Methods:
- Literature review of oncogenic and oncolytic pathogens.
- Analysis of pathogen-induced gene expression and inflammation.
- Examination of pathogen-mediated tumor lysis and immune response.
Main Results:
- Oncogenic pathogens increase cancer risk via genetic alteration or chronic inflammation.
- Oncolytic pathogens induce tumor regression and enhance anti-tumor immunity.
- Non-oncogenic, non-oncolytic pathogens also impact tumor growth and regression.
Conclusions:
- Pathogens can both initiate and resolve cancer, but mechanisms require further elucidation.
- Future research should focus on preventing oncogenic infections and leveraging oncolytic pathogens.
- Understanding all pathogen roles is crucial for developing novel cancer immunotherapies.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Cancer Prevention
Some...
Tumor Immunotherapy
Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

